statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market...

Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market

Apple reports better-than-estimated earnings and expands its buyback program by $110 billion, Amgen 'very encouraged' by preliminary data from a trial of a weight-loss drug, and Expedia reduces its...

These Stocks Moved the Most Today: Apple, Amgen, Expedia, Coinbase, Cloudflare, Fortinet, Live Nation, and More

Investopedia

 Key TakeawaysThe S&P 500 jumped 1.3% on Friday, May 3, 2024, as the latest jobs report showed a cooling labor market, revitalizing hopes for a near-term interest rate cut.Amgen...

S&P 500 Gains and Losses Today: Amgen Soars as Weight-Loss Drug Shows Promise

If Soranus of Ephesus were alive today he'd be mighty surprised.Like his modern-day counterparts in the medical field, the 2nd Century Greek physician considered obesity to be a disease, and he...

Analyst unveils Amgen stock price target after weight-loss drug data

All three of the major indexes (^DJI,^GSPC, ^IXIC) jumped after the April employment report showed the US added 175,000 jobs last month, far fewer than the 240,000 economists had been predicting. The...

Stocks surge as soft jobs report revives Fed rate cut hopes:

TradingView

 Read the original article on Investopedia...

Top Stock Movers Now: Apple, Amgen, Fortinet, and More

Top Midday Stories: Apple's Dividend, Buybacks Announcements; Amgen Obesity Drug Trial Results; Exxon Completes Pioneer Acquisition...

Here Comes Obesity Drug Competition: Amgen Shares Soar On "Very Encouraging" Clinical Trial Update

Amgen earnings beat estimates, and MariTide's promising Phase 2 results suggest significant differentiation from competitors.

 Latest Ratings for AMGN
 DateFirmActionFromTo Feb 2022Morgan...

Amgen Outlook Is Bright, Analyst Predict Obesity-Focused Drug Potential Will Drive Shareholder Value

Amgen's update fueled concerns about potential new competition in the weight loss drug market, sending shares of Novo Nordisk and Eli Lilly lower...

Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Volume	9.64M
52-Wk High	$329.72
52-Wk Low	$211.71

AMGN AMGEN Inc.

About

Feed

News

Sentiment

Earnings

Fundamentals